Features January 2015 Issue

New Drug-Eluting Stents May Be As Safe As Bare-Metal Types

New Drug-Eluting Stents May Be As Safe As Bare-Metal Types

Research also shows second-generation drug-eluding stents are safer than their predecessors when it comes to preventing thrombosis.

The first generation of drug-eluting stents (DES) that came along more than a decade ago were seen as promising tools in the treatment of coronary heart disease. But studies showed that DES raised the risk of stent thrombosis≠óblood clot formation at the site of the stent.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.